Literature DB >> 26838262

Molecular mechanisms of bone formation in spondyloarthritis.

Susana Aideé González-Chávez1, Celia María Quiñonez-Flores1, César Pacheco-Tena2.   

Abstract

Spondyloarthritis comprise a group of inflammatory rheumatic diseases characterized by its association to HLA-B27 and the presence of arthritis and enthesitis. The pathogenesis involves both an inflammatory process and new bone formation, which eventually lead to ankylosis of the spine. To date, the intrinsic mechanisms of the pathogenic process have not been fully elucidated, and our progress is remarkable in the identification of therapeutic targets to achieve the control of the inflammatory process, yet our ability to inhibit the excessive bone formation is still insufficient. The study of new bone formation in spondyloarthritis has been mostly conducted in animal models of the disease and only few experiments have been done using human biopsies. The deregulation and overexpression of molecules involved in the osteogenesis process have been observed in bone cells, mesenchymal cells, and fibroblasts. The signaling associated to the excessive bone formation is congruent with those involved in the physiological processes of bone remodeling. Bone morphogenetic proteins and Wnt pathways have been found deregulated in this disease; however, the cause for uncontrolled stimulation remains unknown. Mechanical stress appears to play an important role in the pathological osteogenesis process; nevertheless, the association of other important factors, such as the presence of HLA-B27 and environmental factors, remains uncertain. The present review summarizes the experimental findings that describe the signaling pathways involved in the new bone formation process in spondyloarthritis in animal models and in human biopsies. The role of mechanical stress as the trigger of these pathways is also reviewed.
Copyright © 2015 Société française de rhumatologie. Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Ankylosis; Mechanosensing; Osteogenesis; Signaling pathways

Mesh:

Substances:

Year:  2016        PMID: 26838262     DOI: 10.1016/j.jbspin.2015.07.008

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  5 in total

Review 1.  The Paradox of Bone Formation and Bone Loss in Ankylosing Spondylitis: Evolving New Concepts of Bone Formation and Future Trends in Management.

Authors:  Marina N Magrey; Muhammad A Khan
Journal:  Curr Rheumatol Rep       Date:  2017-04       Impact factor: 4.592

2.  Positive transcriptional response on inflammation and joint remodelling influenced by physical exercise in proteoglycan-induced arthritis: An animal study.

Authors:  Susana A González-Chávez; César Pacheco-Tena; Celia M Quiñonez-Flores; Gerardo P Espino-Solis; Jessica I Burrola-De Anda; Perla M Muñoz-Morales
Journal:  Bone Joint Res       Date:  2020-05-16       Impact factor: 5.853

3.  Proper mechanical stress promotes femoral head recovery from steroid-induced osteonecrosis in rats through the OPG/RANK/RANKL system.

Authors:  Dapeng Fu; Kairong Qin; Sheng Yang; Jianmin Lu; Haoyi Lian; Dewei Zhao
Journal:  BMC Musculoskelet Disord       Date:  2020-05-02       Impact factor: 2.362

4.  Aberrant upregulation of CaSR promotes pathological new bone formation in ankylosing spondylitis.

Authors:  Xiang Li; Siwen Chen; Zaiying Hu; Dongying Chen; Jianru Wang; Zemin Li; Zihao Li; Haowen Cui; Guo Dai; Lei Liu; Haitao Wang; Kuibo Zhang; Zhaomin Zheng; Zhongping Zhan; Hui Liu
Journal:  EMBO Mol Med       Date:  2020-12-01       Impact factor: 12.137

5.  Circulating Retinol-Binding Protein 4 as a Possible Biomarker of Treatment Response for Ankylosing Spondylitis: An Array-Based Comparative Study.

Authors:  Jialing Wu; Xinyu Wu; Zena Chen; Qing Lv; Mingcan Yang; Xuqi Zheng; Qiuxia Li; Yanli Zhang; Qiujing Wei; Shuangyan Cao; Xiaomin Li; Jun Qi; Minjing Zhao; Zetao Liao; Zhiming Lin; Jieruo Gu
Journal:  Front Pharmacol       Date:  2020-03-10       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.